A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis

Nature Clinical Practice Nephrology

Volumn 3, Issue 2, 2007, Pages 111-115

  Weiss, Andrew S ^a   Lucia, M Scott ^a   Teitelbaum, Isaac ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Circulating fibrocytes; Nephrogenic fibrosing dermopathy; Nephrogenic systemic fibrosis

Indexed keywords

METHYLPREDNISOLONE; THALIDOMIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTRACTURE; ELECTROMYOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; NEPHROGENIC FIBROSING DERMOPATHY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN TIGHTNESS; WEAKNESS;

BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MIDDLE AGED; RENAL DIALYSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN DISEASES;

EID: 33846525037     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0373     Document Type: Article

References (16)

1. Cowper SE et al. (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356: 1000-1001
2. Cassis TB et al. (2006) Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol 45: 56-59
3. Ting WW et al. (2003) Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139: 903-906
4. Daram SR et al. (2005) Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46: 754-759
5. Gibson SE et al. (2006) Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med 130: 209-212
6. Kucher C et al. (2006) Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol 54 (Suppl): S31-S34
7. Cowper SE (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15: 785-790
8. Quan TE et al. (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606
9. Cowper SE et al. (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23: 383-393
10. Mackay-Wiggan JM et al. (2003) Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 48: 55-60
11. Fazeli A et al. (2004) Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link? Arch Dermatol 140: 1401
12. LeBoit PE (2003) What nephrogenic fibrosing dermopathy might be. Arch Dermatol 139: 928-930
13. Grobner T (2006) Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21: 1104-1108
14. US Food and Drug Administration (online 8 June 2006) Public Health Advisory [http://www.fda. gov/cder/drug/advisory/gadolinium_agents.htm] (accessed 24 August 2006)
15. Perazella MA et al. (2003) Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial 16: 276-280
16. Cowper SE (online 14 June 2006) Nephrogenic fibrosing dermopathy [http://www.icnfdr.org] (Accessed 24 August 2006)